Fenbendazole 222 Mg Capsule
NDC Package 85130-100-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Fenbendazole 222 Mg capsules is dewormer. This formulation utilizes a capsule delivery system. Marketed by B & L Healthcare Products Inc, this product is identified by NDC 85130-100.

Identification & Billing

NDC Package Code
85130-100-01
Package Description
120 CAPSULE in 1 BOTTLE, PLASTIC / 222 mol in 1 CAPSULE
Product Code
85130-100
11-Digit Billing Format
85130010001

Clinical Specifications

Proprietary Name
Fenbendazole 222 Mg
Non-Proprietary Name
Fenbendazole 222 Mg
Substance Name
Fenbendazole
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
FENBENDAZOLE 299.35 mg/mol
Usage Information
Dewormer

Regulatory & Marketing

Labeler Name
B & L Healthcare Products Inc
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-01-2015
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (85130-100). Click a package code to view its specific billing and regulatory data.

85130-100-02
90 CAPSULE in 1 BOTTLE, PLASTIC / 444 mol in 1 CAPSULE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85130-100-01 identifies a specific commercial package of 120 capsule in 1 bottle, plastic / 222 mol in 1 capsule of Fenbendazole 222 Mg, a human over the counter drug labeled by B & L Healthcare Products Inc. This capsule is formulated for oral use and contains fenbendazole as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by B & L Healthcare Products Inc on January 01, 2015. The current certification is valid through December 31, 2026.

How is this B & L Healthcare Products Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85130010001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85130-100-01
11-Digit CMS (5-4-2)
85130-0100-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.